Categorynews

Global RNA Analysis/ Transcriptomics Market (2021 to 2030) – Featuring Affymetrix, GE Healthcare and Thermo Fisher Scientific Among Others – ResearchAndMarkets.com

November 10, 2021 Off By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “RNA Analysis/ Transcriptomics Global Market Report 2021: COVID-19 Growth and Change” report has been added to ResearchAndMarkets.com’s offering.

This report provides the strategists, marketers and senior management with the critical information they need to assess the global RNA analysis/ transcriptomics market.

The global RNA analysis/ transcriptomics market is expected to grow from $4.59 billion in 2020 to $5.22 billion in 2021 at a compound annual growth rate (CAGR) of 13.8%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $8.62 billion in 2025 at a CAGR of 13.4%.

Companies Mentioned

Affymetrix Inc.
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
GE Healthcare
Illumina Inc.
Qiagen N.V.
F. Hoffmann-La Roche Ltd.
Sigma-Aldrich Corporation
Thermo Fisher Scientific Inc.
Fluidigm Corporation
Promega Corporation
Biomereiux SA

The report focuses on the RNA analysis/ transcriptomics market which is experiencing strong growth. It gives a guide to the RNA analysis/ transcriptomics market which will be shaping and changing our lives over the next ten years and beyond, including the market’s response to the challenge of the global pandemic.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis

The main types of products in the RNA analysis/ transcriptomics market are reagents/consumables, instruments and software. It is implemented in various areas including clinical diagnostics, drug discovery, toxicogenomics, comparative transcriptomics and RNA interference. Major technologies involved in RNA analysis/ transcriptomics are microarrays, sequencing and polymerase chain reaction RNA interference. RNA analysis is used in clinical diagnosis to detect different RNA species, pathogen RNA splice variants among others useful in the diagnosis of diseases.

North America was the largest region in the RNA analysis/transcriptomics market in 2020. This region is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Technological advancements and innovations in RNA analysis are emerging trends in the RNA analysis/ transcriptomics market. Technologies such as next-generation sequencing (NGS) and RNA interference (RNAi) improve precision and accuracy, which help researchers analyze the transcriptional activity. For instance, Next-generation sequencing developed by Illumina is successfully used in fragmenting DNA/RNA into multiple pieces, adding adapters, sequencing the libraries, and reassembling them to form a genomic sequence.

In October 2020, 10x Genomics, a startup based in the USA, acquired Cartana for an amount of $41.2 million. The acquisition of Cartana is expected to strengthen its approach to develop technologically advanced products. Cartana is a Sweden-based biotechnology player involved in developing in situ RNA analysis technology.

The increasing demand for personalized medicine is expected to drive the growth of the RNA analysis/ transcriptomics market in the coming years. Personalized medicine refers to the customizing of medical treatment to each patient’s unique characteristics. If scientists can implement the necessary practices and processes for personalized clinical care, RNA-Seq will be well-positioned to handle the massive clinical workload. According to a report on personalized medicines by US FDA, 11 drugs out of 44 new drugs approved in the year 2019 were personalized drugs. Moreover, as per the Personalized Medicine Report 2020 published by the Personalized Medicine Coalition (PMC), the number of personalized medicines in the market more than doubled between 2016 and 2020 in the USA. Therefore, the growing demand for the personalized medicines propels the growth of the RNA analysis market.

The countries covered in the RNA analysis/ transcriptomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

For more information about this report visit https://www.researchandmarkets.com/r/liyg38